- Investor company - Focus on anti-cancer therapies - Both preclinical as well as clinical activity - Vaccines - Antibody therapy - Small molecules
Not updated yet!
DROIA is a novel investor company, fully focused on bringing promising cancer therapies to market. We operate from our offices in Luxemburg and Brussels. DROIA has a close relationship with Anti Cancer Fund, a not-for-profit organization aimed at helping patients and doctors to find the best therapeutic solutions for specific cancers. We are therefore extremely dedicated to making a difference in the fight against cancer. This does not preclude our objective to maximize shareholder value creation in our investments. To succeed in this double mission we operate to the highest professional standards. One of those standards is wasting no time. Time is Life in this field. Hence our name: Double Return On Investment, Accelerated: DROIA